Revenue

As FuelCell Energy eyes larger global projects, it hires a legal expert known for scaling power giants, signaling a strategic shift to execution.

A new partnership combines edge computing software and enterprise hardware to ensure retail and logistics operations never stop, even without internet.

With FDA alignment for its rapid postpartum depression therapy and new trials for anxiety, Reunion Neuroscience is pioneering a new era of mental health.

Annexon is poised for a landmark year with potential first-in-class drugs for GBS and GA, promising to reset treatment standards and offer new hope.

With pivotal cancer drug data looming and a new nuclear supply chain, Bicycle Therapeutics is betting big on its novel platform. Will 2026 be its breakout year?

WindRose and Francisco Partners invest in Avalon, signaling a major shift toward tech-driven management of the multi-billion dollar diagnostic testing market.

BioXcel Therapeutics is pushing its drug IGALMI® for home use, a move that could transform mental healthcare but carries significant financial and safety risks.

Princeton-based EDETEK will present its AI-powered clinical trial ecosystem at the J.P. Morgan conference, aiming to capture a slice of a booming market.

With a key FDA filing and pivotal data on the horizon, Pharvaris aims to redefine HAE treatment with its convenient, rapid-acting oral therapy.

FIS finalizes its $12B acquisition of Global Payments' issuer arm and sells its Worldpay stake, creating a new data-driven force in banking tech.

Palladyne AI launches its IQ 2.0 software, a low-code platform aiming to overhaul defense manufacturing in line with new government mandates.

Cineplex expands its free popcorn event to four days, a strategic move to leverage its loyalty program and combat the post-holiday attendance slump.

The burger chain posted positive sales and aggressive 2026 growth plans, navigating weather woes and inflation with new menu items and operational tweaks.

After a lengthy battle, a New York financier is cleared of all charges. Now, his lawsuit against FINRA and Capital Group challenges the system itself.

Amidst a strategic push for profitability, CytoSorbents advances its DrugSorb-ATR device, aiming to revolutionize safety in cardiac surgery.

Utz Brands posted strong 2025 profit growth and market share gains, overcoming retail inventory issues caused by economic headwinds like SNAP delays.

Teladoc Health's enhanced service integrates specialist consults and data analytics, moving beyond urgent care to reshape healthcare costs and patient outcomes.

A new report names QuickBooks Payroll best for integrated time tracking, highlighting a major shift for businesses navigating complex labor laws in 2026.

Following their sold-out 'Corpse Paint' vault, e.l.f. and Liquid Death reunite for a new line of lip balms, proving bizarre marketing is king.

As AI accelerates software creation, TestMu AI (formerly LambdaTest) launches the first agentic quality platform to ensure quality keeps pace.